Letter to the Editor
Smoking cessation and weight gain in patients with cardiovascular disease or risk factor

https://doi.org/10.1016/j.ijcard.2014.01.055Get rights and content

Section snippets

Declaration of interests

J.S. Issa is the principal site investigator in Varenicline Trials promoted by Pfizer.

First page preview

First page preview
Click to open first page preview

References (8)

  • K.A. Perkins et al.

    Addressing women's concerns about weight gain due to smoking cessation

    J Subst Abuse Treat

    (1997)
  • J.S. Issa et al.

    Effectiveness of coadministration of varenicline, bupropion, and serotonin reuptake inhibitors in a smoking cessation program in the real-life setting

    Nicotine Tob Res

    (2013)
  • H.-J. Aubin et al.

    Weight gain in smokers after quitting cigarettes: meta-analysis

    BMJ

    (2012)
  • D.F. Williamson et al.

    Smoking cessation and severity of weight gain in a national cohort

    N Engl J Med

    (1991)
There are more references available in the full text version of this article.
View full text